- This event has passed.
LC-Fatty Acid Oxidation Disorders: Recent Updates on the REN001 Study
August 18, 2022 @ 7:00 pm – 8:00 pm
There was much discussion about current research in FAODs at our recent International Metabolic conference last month. Reneo Pharmaceuticals recently released positive results from the REN001 Phase1b LC-FAOD Study.
Please join us for an update on the Reneo LC-FAOD study. Dr. Alex Dorenbaum, Chief Medical Officer at Reneo Pharmaceuticals will provide background about this clinical study and will answer your questions.
